ProfileGDS4718 / 213144_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 78% 78% 76% 74% 82% 79% 80% 80% 78% 75% 76% 76% 79% 81% 76% 78% 80% 77% 78% 77% 77% 77% 76% 75% 79% 73% 80% 74% 80% 74% 76% 79% 81% 80% 78% 76% 79% 80% 79% 77% 79% 76% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4869277
GSM549102patient 115, normal, homogenized [OPG study]7.5703878
GSM549104patient 119, normal, homogenized [OPG study]7.6517878
GSM549108patient 138, normal, homogenized [OPG study]7.3062376
GSM549119patient 077, normal, homogenized [OPG study]7.1446274
GSM549133patient 032, cancer, homogenized [OPG study]8.2984182
GSM549139patient 042, cancer, homogenized [OPG study]7.786379
GSM549099patient 107, normal, homogenized [OPG study]7.7231380
GSM549109patient 139, normal, homogenized [OPG study]7.7411580
GSM549110patient 046, normal, homogenized [OPG study]7.5695878
GSM549114patient 063, normal, homogenized [OPG study]7.3417275
GSM549122patient 082, normal, homogenized [OPG study]7.4406176
GSM549134patient 033, cancer, homogenized [OPG study]7.4485876
GSM549136patient 036, cancer, homogenized [OPG study]7.8744779
GSM549140patient 044, cancer, homogenized [OPG study]8.1007781
GSM549111patient 047, normal, homogenized [OPG study]7.5055176
GSM549113patient 057, normal, homogenized [OPG study]7.6861978
GSM549132patient 031, cancer, homogenized [OPG study]7.8956680
GSM549137patient 038, cancer, homogenized [OPG study]7.6142377
GSM549142patient 047, cancer, homogenized [OPG study]7.4656978
GSM549100patient 110, normal, homogenized [OPG study]7.4924577
GSM549107patient 135, normal, homogenized [OPG study]7.4993977
GSM549115patient 068, normal, homogenized [OPG study]7.5773377
GSM549116patient 072, normal, homogenized [OPG study]7.4648276
GSM549120patient 078, normal, homogenized [OPG study]7.2710475
GSM549131patient 030, cancer, homogenized [OPG study]7.8654379
GSM549118patient 074, normal, homogenized [OPG study]7.1903873
GSM549129patient 027, cancer, homogenized [OPG study]7.8371580
GSM549123patient 088, normal, homogenized [OPG study]7.2368574
GSM549124patient 006, cancer, homogenized [OPG study]7.8281280
GSM549126patient 015, cancer, homogenized [OPG study]7.2574674
GSM549128patient 025, cancer, homogenized [OPG study]7.549776
GSM549103patient 117, normal, homogenized [OPG study]7.6129579
GSM549117patient 073, normal, homogenized [OPG study]8.0537281
GSM549138patient 041, cancer, homogenized [OPG study]7.9390980
GSM549141patient 045, cancer, homogenized [OPG study]7.7408878
GSM549130patient 028, cancer, homogenized [OPG study]7.4422676
GSM549101patient 111, normal, homogenized [OPG study]7.6643779
GSM549105patient 128, normal, homogenized [OPG study]7.7742680
GSM549106patient 134, normal, homogenized [OPG study]7.893979
GSM549112patient 048, normal, homogenized [OPG study]7.5473377
GSM549125patient 011, cancer, homogenized [OPG study]7.6917679
GSM549127patient 024, cancer, homogenized [OPG study]7.5553676
GSM549135patient 035, cancer, homogenized [OPG study]7.7654678